Monoclonal and Oligoclonal Anti-platelet Factor 4 Antibodies Mediate VITT

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2022 May 13

PMID 35560046

Authors

Adam J Kanack

Antonios Bayas

Gemlyn George

Mouhamed Yazan Abou-Ismail

Bandana Singh

Mindy C Kohlhagen

Noah P Splinter

Monika Christ

Markus Naumann

Karen A Moser

Kristi J Smock

Alison Grazioli

Renren Wen

Demin Wang

David L Murray

Anand Padmanabhan

Affiliations

Soon will be listed here.

Citing Articles

Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19.

Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J Blood. 2024; .

PMID: 39576992 PMC: 11811936. DOI: 10.1182/blood.2024025010.

Diagnostic Complexity in Monoclonal Gammopathy of Thrombotic Significance.

Kanack A, Leung N, Padmanabhan A N Engl J Med. 2024; 391(20):1961-1963.

PMID: 39565997 PMC: 11581683. DOI: 10.1056/NEJMc2409428.

Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance.

Salmasi G, Murray D, Padmanabhan A N Engl J Med. 2024; 391(6):570-571.

PMID: 39115069 PMC: 11315357. DOI: 10.1056/NEJMc2406453.

Identifying and reducing risks of neurological complications associated with vaccination.

Handunnetthi L, Ramasamy M, Turtle L, Hunt D Nat Rev Neurol. 2024; 20(9):541-554.

PMID: 39112653 DOI: 10.1038/s41582-024-01000-7.

Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders.

Zhang Y, Bissola A, Treverton J, Hack M, Lychacz M, Kwok S J Clin Med. 2024; 13(4).

PMID: 38398325 PMC: 10889051. DOI: 10.3390/jcm13041012.

References

Warkentin T, Kelton J . Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001; 344(17):1286-92. DOI: 10.1056/NEJM200104263441704. View

Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M . Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. 2021; 397(10285):e11. PMC: 8046413. DOI: 10.1016/S0140-6736(21)00872-2. View

Warkentin T . Laboratory diagnosis of heparin-induced thrombocytopenia. Int J Lab Hematol. 2019; 41 Suppl 1:15-25. DOI: 10.1111/ijlh.12993. View

Huynh A, Arnold D, Kelton J, Smith J, Horsewood P, Clare R . Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. J Thromb Haemost. 2018; 17(2):389-399. DOI: 10.1111/jth.14369. View

Li Z, Liu W, Park K, Sachais B, Arepally G, Cines D . Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood. 2002; 99(4):1230-6. DOI: 10.1182/blood.v99.4.1230. View

Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M . Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021; 384(23):2202-2211. PMC: 8112532. DOI: 10.1056/NEJMoa2105385. View

Kanack A, Singh B, George G, Gundabolu K, Koepsell S, Abou-Ismail M . Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. Am J Hematol. 2022; 97(5):519-526. PMC: 8986571. DOI: 10.1002/ajh.26488. View

Staibano P, Arnold D, Bowdish D, Nazy I . The unique immunological features of heparin-induced thrombocytopenia. Br J Haematol. 2017; 177(2):198-207. DOI: 10.1111/bjh.14603. View

George G, Friedman K, Curtis B, Lind S . Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination. Am J Hematol. 2021; 96(8):E301-E303. DOI: 10.1002/ajh.26237. View

10.

Schultz N, Sorvoll I, Michelsen A, Munthe L, Lund-Johansen F, Ahlen M . Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021; 384(22):2124-2130. PMC: 8112568. DOI: 10.1056/NEJMoa2104882. View

11.

See I, Lale A, Marquez P, Streiff M, Wheeler A, Tepper N . Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. Ann Intern Med. 2022; 175(4):513-522. PMC: 8787833. DOI: 10.7326/M21-4502. View

12.

Schonborn L, Thiele T, Kaderali L, Gunther A, Hoffmann T, Seck S . Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient. Blood. 2022; 139(12):1903-1907. PMC: 8816791. DOI: 10.1182/blood.2021014214. View

13.

Tiede A, Sachs U, Czwalinna A, Werwitzke S, Bikker R, Krauss J . Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood. 2021; 138(4):350-353. PMC: 8084604. DOI: 10.1182/blood.2021011958. View

14.

Murray D, Puig N, Kristinsson S, Usmani S, Dispenzieri A, Bianchi G . Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood Cancer J. 2021; 11(2):24. PMC: 7873248. DOI: 10.1038/s41408-021-00408-4. View

15.

Arepally G, McKenzie S, Jiang X, Poncz M, Cines D . Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood. 1997; 89(2):370-5. View

16.

Pavord S, Scully M, Hunt B, Lester W, Bagot C, Craven B . Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med. 2021; 385(18):1680-1689. PMC: 10662971. DOI: 10.1056/NEJMoa2109908. View

17.

Irani M, Siegal E, Jella A, Aster R, Padmanabhan A . Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia. Transfusion. 2018; 59(3):931-934. PMC: 6402961. DOI: 10.1111/trf.15105. View

18.

Muir K, Kallam A, Koepsell S, Gundabolu K . Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med. 2021; 384(20):1964-1965. PMC: 8063883. DOI: 10.1056/NEJMc2105869. View

19.

Murray D, Dasari S . Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis. Clin Lab Med. 2021; 41(2):203-219. DOI: 10.1016/j.cll.2021.03.003. View

20.

Abou-Ismail M, Moser K, Smock K, Lim M . Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. Am J Hematol. 2021; 96(9):E346-E349. PMC: 8212083. DOI: 10.1002/ajh.26265. View